This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Olivier Ludemann-Hombourger, PhD
Director, Global Innovation and Technology at PolyPeptide Group
Speaker

Profile

Olivier Ludemann‑Hombourger serves as Global Director of Innovation & Technology and is a member of the Management Committee at PolyPeptide. He holds a PhD from the Institut National Polytechnique de Lorraine (France), completed in collaboration with Novasep Process, where he subsequently led R&D activities for a decade. He later joined Lonza in Braine‑l’Alleud (Belgium) as Head of Operations before moving to PolyPeptide, where he spent seven years as General Manager of the French subsidiary. Since 2019, Olivier has held his current global leadership role, steering the Group’s innovation strategy and technological development across its worldwide operations.

Agenda Sessions

  • Driving Time‑to‑Market Excellence: Integrated Lab Innovations and Modular Production Models

    11:15am